Identification of hepatitis B virus A1762T/G1764A double mutant strain in patients in Southern Brazil

Infection by hepatitis B virus (HBV) is a worldwide public health problem. Chronic HBV infection with high viral replication may lead to cirrhosis and/or hepatocellular carcinoma. Mutant HBV strains, such as the HBV A1762T/G1764A double mutant, have been associated with poor prognosis and higher risk of the patient for developing cirrhosis and/or hepatocellular carcinoma. This study analyzed the presence of the HBV A1762T/G1764A double mutant in patients with chronic HBV and its association with clinical parameters such as viral load, aminotransferases, and HBV antigens. A total of 49 patients with chronic hepatitis B were included in the study, and the HBV A1762T/G1764A double mutant strain was detected in four samples (8.16%) by polymerase chain reaction followed by restriction fragment length analysis (PCR-RFLP). The viral load was not significantly different between patients with or without the double mutant strain (p = 0.43). On the other hand, carriers of the HBV A1762T/G1764A double mutant had higher levels of ALT (p = 0.0028), while AST levels did not differ between groups (p = 0.051). In this study, 75% of the samples with the HBV A1762T/G1764A double mutation were HBeAg negative and anti-HBe positive, reflecting seroconversion even though they still displayed high viral loads. Our study has shown that the HBV A1762T/G1764A double mutant strain circulates in Brazilian patients, and is associated with elevated levels of ALT and HBeAg seroconversion.

• Publication year

  2017

• Venue

  Brazilian Journal of Infectious Diseases

• Publication date

  2017-06-09

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.bjid.2017.05.002PMID 28606415PMCID 9425463
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Laurindo-Teodorescu L, Teixeira PR. Histórias da aids no Brasil, 1983-2003. Brasília: Ministério da Saúde/Secretaria de Vigilância em Saúde/Departamento de DST, Aids e Hepatites Virais; 2015.

  2018cited by this paper
• Present and future therapies of hepatitis B: From discovery to cure

  2015cited by this paper
• Precore Mutation of Hepatitis B Virus May Contribute to Hepatocellular Carcinoma Risk: Evidence from an Updated Meta-Analysis

  2012cited by this paper
• Folliculin, the Product of the Birt-Hogg-Dube Tumor Suppressor Gene, Interacts with the Adherens Junction Protein p0071 to Regulate Cell-Cell Adhesion

  2012cited by this paper
• Molecular Epidemiology of Hepatitis B Virus

  2011cited by this paper
• Ultrasensitive Quantification of Hepatitis B Virus A1762T/G1764A Mutant by a SimpleProbe PCR Using a Wild-Type-Selective PCR Blocker and a Primer-Blocker-Probe Partial-Overlap Approach

  2011cited by this paper
• Treatment of chronic hepatitis B.

  2010cited by this paper
• Genotyping of hepatitis B virus in a cohort of patients evaluated in a hospital of Porto Alegre, South of Brazil.

  2010cited by this paper
• Molecular biology of the hepatitis B virus and role of the X gene.

  2010cited by this paper
• Prospective Evaluation of Hepatitis B 1762T/1764A Mutations on Hepatocellular Carcinoma Development in Shanghai, China

  2009cited by this paper
• Influence of hepatitis B virus X and core promoter mutations on hepatocellular carcinoma among patients infected with subgenotype C2

  2009cited by this paper
• Associations Between Hepatitis B Virus Mutations and the Risk of Hepatocellular Carcinoma: A Meta-Analysis

  2009cited by this paper
• Hepatitis B virus genotypes circulating in Brazil: molecular characterization of genotype F isolates

  2007cited by this paper
• The Francisella pathogenicity island protein IglA localizes to the bacterial cytoplasm and is needed for intracellular growth

  2007cited by this paper
• Influence of Hepatitis B Virus X and Core Promoter Mutations on Hepatocellular Carcinoma among Patients Infected with Subgenotype C2

  2007cited by this paper
• Hepatitis B virus genotype E detected in Brazil in an African patient who is a frequent traveler.

  2007cited by this paper
• [Natural history of chronic hepatitis B].

  2007cited by this paper
• História natural da hepatite crônica B

  2007cited by this paper
• Simultaneous Quantification and Genotyping of Hepatitis B Virus for Genotypes A to G by Real-Time PCR and Two-Step Melting Curve Analysis

  2006cited by this paper
• HBV virological assessment.

  2006cited by this paper
• Therapeutic implications of hepatitis B virus genotypes

  2005cited by this paper
• Genome Replication, Virion Secretion, and e Antigen Expression of Naturally Occurring Hepatitis B Virus Core Promoter Mutants

  2003cited by this paper
• [Prevalence of hepatitis B virus markers within household contacts in the State of Amazonas].

  2003cited by this paper
• Low HBeAg Serum Levels Correlate with the Presence of the Double A1762T/G1764A Core Promoter Mutation and a Positive Response to Interferon in Patients with Chronic Hepatitis B Virus Infection

  2003cited by this paper
• Prevalência de marcadores para o vírus da hepatite B em contatos domiciliares no Estado do Amazonas

  2003cited by this paper
• Genetic variability in hepatitis B viruses.

  2002cited by this paper
• Hepatitis B viral genotypes: Clinical relevance and molecular characteristics

  2002cited by this paper
• Molecular diagnosis of viral hepatitis.

  2002cited by this paper
• Management of hepatitis B: 2000--summary of a workshop.

  2001cited by this paper
• Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B.

  2000cited by this paper
• [Diagnosis and treatment of hepatitis B].

  2000cited by this paper
• Hepatitis B virus: genotypes and subtypes in Brazilian hemodialysis patients.

  1999cited by this paper
• T1762/A1764 variants of the basal core promoter of hepatitis B virus; serological and clinical correlations in Chinese patients.

  1999cited by this paper
• Wild-type levels of pregenomic RNA and replication but reduced pre-C RNA and e-antigen synthesis of hepatitis B virus with C(1653) --> T, A(1762) --> T and G(1764) --> A mutations in the core promoter.

  1998cited by this paper
• Enhancement of Hepatitis B Virus Infection by Noninfectious Subviral Particles

  1998cited by this paper
• Global programme for control of hepatitis B infection.

  1995cited by this paper
• The precore/core promoter mutant (T1762A1764) of hepatitis B virus: clinical significance and an easy method for detection.

  1995cited by this paper
• Treatment of chronic hepatitis B

  1994cited by this paper
• Effect of Alpha-Interferon Treatment in Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis B

  1993cited by this paper
• Replication of the genome of a hepatitis B--like virus by reverse transcription of an RNA intermediate.

  1982cited by this paper
• New Specificities in Australia Antigen Positive Sera Distinct from the Le Bouvier Determinants

  1972cited by this paper
• New specificities in Australia antigen positive sera distinct from the Le Bouvier determinants.

  1972cited by this paper

• Hepatitis B-related hepatocellular carcinoma: surveillance strategy directed by immune-epidemiology

  2021cites this paper
• Prevalence of Dual-Positivity for Both Hepatitis B e Antigen and Hepatitis B e Antibody Among Hospitalized Patients with Chronic Hepatitis B Virus Infection

  2021cites this paper
• Early changes in quasispecies variant after antiviral therapy for chronic hepatitis B.

  2018cites this paper